Clindamycin is not a recommended antibiotic for acute otitis media in adults
I would not recommend clindamycin for treating acute otitis media (AOM) in this 135.4-pound (61 kg) adult. The available evidence does not support clindamycin as a first-line or even alternative agent for uncomplicated AOM.
Why Clindamycin is Not Appropriate for AOM
The WHO Pocket Book guidelines specifically recommend amoxicillin 40 mg/kg twice daily for 5 days as the treatment of choice for acute otitis media 1. For a 61 kg adult, this would be approximately 2,440 mg daily (1,220 mg twice daily). Alternative options include co-trimoxazole if amoxicillin resistance is not a local concern 1.
Clindamycin lacks adequate coverage for the primary pathogens causing AOM, which are Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis 2. While clindamycin has excellent activity against pneumococcus, it has no activity against H. influenzae or M. catarrhalis, both of which are gram-negative organisms and common causes of AOM 2.
What the Evidence Actually Shows
The IDSA MRSA guidelines mention clindamycin dosing (300-450 mg PO three times daily for adults) only in the context of skin/soft tissue infections, pneumonia, and bone/joint infections—not for otitis media 3.
French guidelines for respiratory infections emphasize that when beta-lactamase-producing organisms are suspected in otitis media, appropriate choices include amoxicillin-clavulanate, cefpodoxime-proxetil, or cefuroxime-axetil—again, clindamycin is not mentioned 2.
Research studies examining AOM treatment consistently focus on amoxicillin-based regimens, with clindamycin only mentioned as a potential option when penicillin-resistant pneumococcus is suspected in combination with other agents to cover gram-negative pathogens 4, 5.
The Correct Approach for This Patient
For this 61 kg adult with AOM, the evidence-based recommendation is:
- First-line: Amoxicillin 500 mg three times daily OR high-dose amoxicillin 1000 mg twice daily for 5-10 days
- If recent antibiotic use or treatment failure: Amoxicillin-clavulanate (high-dose formulation)
- If true penicillin allergy: A respiratory fluoroquinolone (levofloxacin, moxifloxacin) would be more appropriate than clindamycin 6
Critical Pitfall
The major pitfall here is assuming that clindamycin's activity against gram-positive organisms makes it suitable for AOM. This would leave H. influenzae and M. catarrhalis untreated, potentially leading to treatment failure. If clindamycin were to be considered at all (which it shouldn't be for uncomplicated AOM), it would need to be combined with an agent covering gram-negative organisms, such as cefixime 6.
Bottom line: Choose amoxicillin or amoxicillin-clavulanate for this patient, not clindamycin.